NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Distribution · USD

Cardinal Health, Inc. (CAH) Stock Analysis

Cardinal Health, Inc. (CAH) is a Medical Distribution stock listed on NYSE and quoted in US Dollar.

CAH

$247.18

−$1.43 (−0.58%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CAH with… →

CAH Key Statistics

As of Sep 4, 2026
Trading
Open
$246.34
Previous Close
$248.61
Day's Range
246.29–249.29
52-Week Range
145.87–258.30
Volume
1.55M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.52
Valuation
Market Cap
$57.49B
P/E Ratio
34.38
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
17.56
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.24
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.23
EPS (ttm)Profit attributable to each share over the last twelve months.
7.19
Financials (FY)
Revenue (FY)
$222.58B−1.87%
Net Income (FY)
$1.56B+83.22%
Profit marginThe share of revenue left as profit after all costs and taxes.
0.67%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
232.58M
1-Year Return
+67.24%
Dividend and dates
Dividend
$2.06+0.83%
Ex-Dividend Date
October 1, 2026
Earnings Date
November 5, 2026estimated
Avg Volume
2.17M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CAH Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+21.14%
2025+76.25%
2024+19.01%
2023+34.15%
2022+54.08%
2021−0.40%
2020+10.09%
2019+18.04%
2018−24.50%
2017−12.65%
2016 (partial year)−13.06%

As of September 4, 2026.

CAH Revenue and Earnings by Fiscal Year

FY ends June
Fiscal yearRevenueNet incomeNet margin
2025$222.58B$1.56B0.7%
2024$226.83B$852.00M0.4%
2023$204.98B$330.00M0.2%
2022$181.33B−$938.00M−0.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$222.58B$8.17B$2.32B$1.56B0.7%
2024$226.83B$7.41B$2.13B$852.00M0.4%
2023$204.98B$6.87B$1.79B$330.00M0.2%
2022$181.33B$6.48B$1.65B−$938.00M−0.5%

Annual figures as reported, in the company's reporting currency. As of June 30, 2025.

CAH Dividend History

$2.03+34.4% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$1.543—
2025$2.034+34.4%
2024$1.513−24.3%
2023$2.004+1.0%
YearDividends per sharePaymentsChange
2026 (partial year)$1.543—
2025$2.034+34.4%
2024$1.513−24.3%
2023$2.004+1.0%
2022$1.984+1.0%
2021$1.964+1.0%
2020$1.944+1.0%
2019$1.924+1.5%
2018$1.894+3.0%
2017$1.844+104.3%
2016$0.902—

Most recent payment: $0.51 per share, ex-dividend July 1, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

CAH Valuation vs Medical Distribution Median

Median of 13 stocks
MetricCAHMedical Distribution medianvs median
P/E34.3825.7833% above
P/S ratio0.230.3637% below
Profit margin0.67%−4.03%4.7 pts above

Medians across 13 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Cardinal Health, Inc. (CAH) at $57.49B. It is classified in the Medical Distribution industry, within the Healthcare sector. The company reports 58,788 employees.

Over the past 52 weeks the price has ranged from $145.87 to $258.30. The most recent close on file for CAH is $247.18, dated September 4, 2026. That is −$1.43 (−0.58%) against the previous close. The latest close sits 69.45% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $222.58B. That is −1.87% against the prior fiscal year, when revenue was $226.83B. The same year closed with net income of $1.56B. That is +83.22% against the prior fiscal year. Profit margin runs at 0.67%. That is 4.7 percentage points above the Medical Distribution median of −4.03%. Earnings per share on a trailing basis come to 7.19.

Across the 4 fiscal years on file, revenue moves from $181.33B in 2022 to $222.58B in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

CAH trades at a trailing price-to-earnings ratio of 34.38. That is 33.36% above the Medical Distribution median of 25.78. On forward earnings the ratio is 17.56. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.24. Measured against sales, the shares trade at 0.23 times revenue. On price-to-sales that is 37.41% below the Medical Distribution median of 0.36. 13 Medical Distribution companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is +67.24%. Across 10 years the annualized return works out at +15.14%. The reported beta is 0.52. Daily returns over the trailing 10 years annualize to a volatility of 29.32%.

Growth & Income

Shareholders receive a dividend, yielding 0.83% on the latest price. That is 0.1 percentage points above the Medical Distribution median yield of 0.71%. The indicated annual rate is $2.06 a share. The ex-dividend date on file is October 1, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $1.54 a share. The year before, 2025, totalled $2.03 a share.

So far in 2026 the price is +21.14%. The strongest complete calendar year on file is 2025 at +76.25%; the weakest is 2018 at −24.50%. Of the 9 complete calendar years on file, 6 finished higher.

Peer Comparison

Cardinal Health, Inc. (CAH) operates in the Medical Distribution industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Cardinal Health, Inc. CAH $57.49B 34.4
McKesson Corporation MCK $105.86B 24.7
Cencora, Inc. COR $63.15B 25.1
Henry Schein, Inc. HSIC $10.01B 26.5

The Medical Distribution industry average P/E ratio is 25.8x. Cardinal Health, Inc. trades at a P/E of 34.4.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Distribution Stocks

MCK

McKesson Corporation

$105.86B

 COR

Cencora, Inc.

$63.15B

 HSIC

Henry Schein, Inc.

$10.01B

 AHG

Akso Health Group

$726.49M

 FOCL

EDAP TMS S.A.

$190.70M

 QIPT

Quipt Home Medical Corp

$162.30M
View all Medical Distribution stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Cardinal Health, Inc.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Visit website →